Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for hyperactivity and attention difficulties in children and individuals. In Canada, its distribution is managed by Health Canada. https://lisdexamfetamine-pharmac200683.p2blogs.com/41420654/vyvanse-in-canada-a-comprehensive-guide